The appropriate framing for every outcome discussed above is observed in research models or preclinical/experimental, never demonstrated in humans. Limitations of the Injectable/Systemic GHK-Cu Evidence Several specific limitations constrain what can be concluded, and they compound one another
Harris SG, Padilla J, Koumas L, Ray D, Phipps RP (2002) Prostaglandins as modulators of immunity
Leslie NR, Downes CP (2002) PTEN: the down side of PI 3-kinase signalling
"Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen"
Three small studies of vitamin E therapy in HBV-infected children and adults suggest a possible role for the antioxidant in the clearance of HBV DNA, adaptation of immune response to the viral antigen, and normalization of liver enzymes levels (Fiorino 2011)
Moon J et al